Amylin Pharmaceuticals to Present at Lehman Brothers Small Cap Conference
November 10 2005 - 4:15PM
PR Newswire (US)
SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at the
Lehman Brothers Small Cap Conference on Thursday, November 17, 2004
at 2:15 p.m. PT in Carlsbad, California. Daniel M. Bradbury, Chief
Operating Officer of Amylin Pharmaceuticals, will be providing a
corporate overview. The live presentation and breakout session will
be webcast, and recordings will be made available following the
event. The webcasts and recordings will be accessible through
Amylin's corporate website, located at http://www.amylin.com/. To
access the live webcasts, please log on to Amylin's site
approximately fifteen minutes prior to the presentation to register
and download any necessary audio software. Amylin Pharmaceuticals
is committed to improving the lives of people with diabetes and
other metabolic diseases through the discovery, development and
commercialization of innovative, cost-effective medicines.
DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Alice Bahner,
Executive Director, Investor Relations of Amylin Pharmaceuticals,
Inc., +1-858-642-7272 Web site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024